Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

90114

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, on what dates since 1 July 2014 NHS England has discussed with the National Institute for Health and Care Excellence (NICE) reforming the way in which NICE assesses the cost-effectiveness of cancer drugs; what the content of those discussions was; and if he will make a statement.
tabling member constituency	Bromley and Chislehurst
tabling member printed	Robert Neill
uin	207578
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>I understand that the National Institute for Health and Care Excellence (NICE) and NHS England met on 28 July, 4 August and 26 August to discuss arrangements for the Cancer Drugs Fund, including its interaction with the NICE appraisal process.</p><p> </p><p> </p><p> </p><p>NICE recently consulted on options for better assessing the value of new drugs and is currently considering the responses to that exercise.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 08/09/2014 15:12:00 answering member 4020 label Biography information for George Freeman
tabling member	1601 label Biography information for Sir Robert Neill

90117

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the forecast level of expenditure on the Cancer Drugs Fund will be in the 2014-15 financial year.
tabling member constituency	Bromley and Chislehurst
tabling member printed	Robert Neill
uin	207589
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p>NHS England has oversight of the Cancer Drugs Fund.</p><p>We are advised that NHS England has not published a forecast for expenditure through the Cancer Drugs Fund in 2014-15.</p><p>On 28 August, we announced that the size of the Fund would be increased to £280 million in both 2014-15 and 2015-16.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 08/09/2014 16:15:08 answering member 4020 label Biography information for George Freeman
tabling member	1601 label Biography information for Sir Robert Neill

90119

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what outturn expenditure on the Cancer Drugs Fund was in the 2013-14 financial year, for each treatment funded.
tabling member constituency	Bromley and Chislehurst
tabling member printed	Robert Neill
uin	207590
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>NHS England has published figures which show that in 2013-14, overall expenditure through the Cancer Drugs Fund was £230,539,005. I understand that NHS England has no plans to publish a further breakdown. Further information can be found at:</p><p> </p><p> </p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2014/08/cdf-summ-fin-pos-13-14.pdf</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 08/09/2014 14:04:32 answering member 4020 label Biography information for George Freeman
tabling member	1601 label Biography information for Sir Robert Neill

90128

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how community pharmacies are paid for the delivery of immunisation services in each area of the UK where NHS England commissions them to do so.
tabling member constituency	Reigate
tabling member printed	Crispin Blunt
uin	207587
answer	answer is ministerial correction date of answer 11/09/2014 answer text <p> </p><p>Information is not held centrally by NHS England on immunisation services commissioned locally from community pharmacists.</p><p> </p><p> </p><p> </p><p>NHS England has advised that such immunisation services are commissioned by NHS England, through service level agreements, as local enhanced services within the community pharmacy contractual framework. As this type of service is commissioned according to local need, actual payments will vary.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 207586 question first answered 11/09/2014 14:04:34 answering member 4020 label Biography information for George Freeman
tabling member	104 label Biography information for Crispin Blunt

90130

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, in which areas NHS England commissioned immunisation services from community pharmacies in the 2013-14 financial year; what estimate he has made of the number of community pharmacies which were commissioned to deliver immunisation services in each area; what estimate he has made of the number of doses of vaccine which were delivered though community pharmacies in the 2013-14 financial year in each area; and if he will make a statement.
tabling member constituency	Reigate
tabling member printed	Crispin Blunt
uin	207586
answer	answer is ministerial correction date of answer 11/09/2014 answer text <p> </p><p>Information is not held centrally by NHS England on immunisation services commissioned locally from community pharmacists.</p><p> </p><p> </p><p> </p><p>NHS England has advised that such immunisation services are commissioned by NHS England, through service level agreements, as local enhanced services within the community pharmacy contractual framework. As this type of service is commissioned according to local need, actual payments will vary.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 207587 question first answered 11/09/2014 14:04:34 answering member 4020 label Biography information for George Freeman
tabling member	104 label Biography information for Crispin Blunt

90135

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the statement by Peter Clark of NHS England that cancer drugs on the list of treatments which are approved for funding must be re-evaluated, reported in The Guardian's article of 28 August 2014 entitled 'Cancer Drugs Fund gets £160 million more for innovative treatments' through what process cancer drugs will be re-evaluated; and whether cancer drugs will be subject to assessments of their cost-effectiveness.
tabling member constituency	Bromley and Chislehurst
tabling member printed	Robert Neill
uin	207582
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>NHS England has oversight of the Cancer Drugs Fund.</p><p> </p><p> </p><p> </p><p>NHS England has advised that work is currently underway to determine the process for reviewing drugs on its national list of cohort policies and on how best to assess costs in relation to clinical benefit delivered.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 207644 question first answered 08/09/2014 14:07:47 answering member 4020 label Biography information for George Freeman
tabling member	1601 label Biography information for Sir Robert Neill

90136

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what cost-per-quality-adjusted life-year thresholds NHS England will attach to its assessments of the cost-effectiveness of cancer drugs for the purposes of assessing whether they should be funded through the Cancer Drugs Fund; and if he will make a statement.
tabling member constituency	Bromley and Chislehurst
tabling member printed	Robert Neill
uin	207644
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>NHS England has oversight of the Cancer Drugs Fund.</p><p> </p><p> </p><p> </p><p>NHS England has advised that work is currently underway to determine the process for reviewing drugs on its national list of cohort policies and on how best to assess costs in relation to clinical benefit delivered.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 207582 question first answered 08/09/2014 14:07:47 answering member 4020 label Biography information for George Freeman
tabling member	1601 label Biography information for Sir Robert Neill

90148

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his Department's policy is on categorising modification to genomic DNA in mitochondria through pronuclear transfer or maternal spindle transfer as genetic modification.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	207754
answer	answer is ministerial correction date of answer 05/09/2014 answer text <p>The Department decided that, because there is no existing universally agreed definition of genetic modification in humans, it would adopt a working definition. The definition that has been adopted is that genetic modification involves the germ-line modification of nuclear DNA (in the chromosomes) that can be passed on to future generations. We will keep this working definition under review.</p><p> </p><p>The proposed mitochondrial donation techniques do not constitute genetic modification.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 05/09/2014 14:26:49 answering member 4020 label Biography information for George Freeman previous answer version 18114 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
tabling member	446 label Biography information for Jim Dobbin

90152

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions he has had with his counterpart in the Northern Ireland Executive on ensuring availability of drugs to treat cancer and MS in all parts of the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	207704
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p>We have had no such discussions.</p><p> </p><p>As the hon. Member will be aware, health is devolved in Northern Ireland and is the responsibility of the Department of Health, Social Services and Public Safety in the Northern Ireland Executive.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 08/09/2014 16:22:16 answering member 4020 label Biography information for George Freeman
tabling member	4131 label Biography information for Jim Shannon

90154

registered interest
date	01/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sildenafil: Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people in each age group were prescribed Viagra through the NHS in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	207708
answer	answer is ministerial correction date of answer 08/09/2014 answer text <p>Information is not collected centrally on the number of people prescribed medicines or the medical condition being treated. However, information is available on the number of prescription items dispensed in the community in England.</p><p>Viagra is a brand name for the chemical Sildenafil. The table below shows the number of prescription items dispensed for Sildenafil, broken down by brand names, for the last five years.</p><p>The number of prescription items for Sildenafil (British National Formulary (BNF) Section 7.4.5 Drugs for erectile dysfunction), by brand name, written in the United Kingdom and dispensed in the community, in England (000s) <sup>1</sup></p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Napatra</p></td><td><p>Sildenafil</p></td><td><p>Viagra</p></td><td><p>Total</p></td></tr><tr><td><p>2009</p></td><td><p>-</p></td><td><p>1.1</p></td><td><p>1,231.8</p></td><td><p>1,232.9</p></td></tr><tr><td><p>2010</p></td><td><p>-</p></td><td><p>1.3</p></td><td><p>1,274.8</p></td><td><p>1,276.1</p></td></tr><tr><td><p>2011</p></td><td><p>-</p></td><td><p>1.1</p></td><td><p>1,278.3</p></td><td><p>1,279.4</p></td></tr><tr><td><p>2012</p></td><td><p>-</p></td><td><p>1.4</p></td><td><p>1,286.2</p></td><td><p>1,287.6</p></td></tr><tr><td><p>2013 <sup>2</sup></p></td><td><p>0.6</p></td><td><p>830.7</p></td><td><p>566.6</p></td><td><p>1,397.9</p></td></tr></tbody></table><p><em>Notes</em>:</p><p><sup>1 </sup>Figures are for BNF Section 7.4.5 Drugs for erectile dysfunction only. Sildenafil also appears in BNF Section 2.5.1 Vasodilator antihypertensive drugs.</p><p><sup>2 </sup>In June 2013 Viagra came of patent. There was a shift in prescribing practice with an increase in prescribing of Sildenefil by its generic name and a corresponding decline in the prescribing of the branded Viagra.</p><p><em>Source</em>: Prescription Cost Analysis provided by the Health and Social Care Information Centre</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 08/09/2014 14:50:25 answering member 4020 label Biography information for George Freeman
tabling member	4131 label Biography information for Jim Shannon